Measles Cases Confirmed in Maryland as Outbreak Continues to Spread Across US

On April 19, 2026, the Maryland Department of Health confirmed the state's first measles case of the year — a Baltimore-area resident who contracted the virus during international travel and passed through BWI Airport's international terminal on April 12 [1]. Health officials identified multiple possible exposure sites over the following days, including a FastMed Urgent Care clinic and Sinai Hospital's emergency department, and urged anyone present at those locations to monitor for symptoms for 21 days [2].

Maryland's single case is, by the numbers, a small addition to a much larger problem. As of April 16, 2026, the CDC had confirmed 1,748 measles cases across 33 jurisdictions since January — and the year is less than four months old [3]. The 2025 total reached 2,288 cases, more than any year since 1992 [4]. Taken together, the two-year surge has placed the country's measles elimination status — a designation the US earned in 2000 after decades of vaccination campaigns — under formal review.

Source: CDC Measles Data

Data as of Apr 16, 2026CSV

The Scale of the Current Outbreak

The 2026 caseload already exceeds the 1,274 cases reported during the 2019 outbreak, which until recently was the worst since elimination was declared [3]. Nineteen new outbreaks have been identified in 2026, and 94% of confirmed cases — 1,637 of 1,748 — are linked to outbreaks, with 1,249 of those traced to outbreaks that began in 2025 [3].

Cases have been reported in Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kentucky, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Mexico, New York City, New York State, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington, and Wisconsin [3]. South Carolina has reported the highest caseload at 991 cases, followed by Utah at 358 [5].

Ninety-three percent of confirmed cases in 2026 involved individuals who were unvaccinated or whose vaccination status was unknown [4]. Children under 5 years old accounted for 23% of cases [5]. Three deaths were recorded in the US during 2025, part of a total 28 deaths across the Americas region [6].

Vaccination Coverage: A Slow Erosion

The epidemiological math behind the resurgence is straightforward. Measles is among the most contagious diseases known — a single infected person can transmit it to 12 to 18 others in a susceptible population. Virologists have long cited 95% vaccination coverage as the threshold needed for herd immunity, the level at which enough people are immune to prevent sustained chains of transmission [7].

National kindergarten MMR vaccination coverage has fallen steadily from 95.2% during the 2019-2020 school year to 92.5% in 2024-2025, leaving approximately 286,000 kindergartners unprotected in the most recent school year alone [4]. Only 10 states reported coverage at or above 95% [4].

Source: CDC MMWR

Data as of Sep 1, 2025CSV

The variation across states is stark. Idaho reported the lowest kindergarten MMR coverage at 78.5%, while Connecticut led at 98.2% [4]. A county-level analysis published in JAMA found that MMR coverage fell below 95% in 990 of 1,501 counties studied across 37 states [8].

Maryland, where the latest case was confirmed, maintains relatively strong statewide coverage at 96.4% for the 2024-2025 school year — a slight decrease from the previous year [9]. But county-level data reveals significant pockets of vulnerability. Kent County's kindergarten MMR rate stands at 88%, the only Maryland county below the herd immunity threshold, with nearly 5% of kindergartners enrolled under religious exemptions [9].

Source: CDC MMWR

Data as of Sep 1, 2025CSV

Who Is at Risk

The populations driving transmission fall into distinct categories with different underlying causes.

Unvaccinated by parental choice. The largest share of cases — over 90% — involves individuals who are unvaccinated [4]. In many affected communities, parents have declined vaccination based on philosophical, religious, or safety concerns. Religious exemptions to school immunization requirements have risen in several states. In Kent County, Maryland, religious exemptions among kindergartners reached nearly 5%, compared to less than 1% claiming medical exemptions [9].

Undervaccinated due to access barriers. Pandemic-era disruptions to routine immunization schedules left millions of children behind on their shots. COVID-19 lockdowns interrupted vaccination programs globally [10], and recovery has been uneven. In the US, federal funding cuts have compounded the problem. In March 2025, the federal government terminated $11.4 billion in grants to state and local health departments — funds originally allocated for COVID-19 response but which had been supporting broader infectious disease control efforts, including vaccination outreach [11]. In Washoe County, Nevada, those cuts resulted in the loss of two contract staffers who organized vaccination events [11].

Immunocompromised individuals. People undergoing chemotherapy, organ transplant recipients on immunosuppressive drugs, and others with compromised immune systems cannot receive the MMR vaccine because it contains live attenuated virus [12]. These individuals depend entirely on community immunity for protection. While precise national estimates of this population are difficult to pin down, they include cancer patients, transplant recipients, and people with certain immune disorders — a group numbering in the millions.

Infants under 12 months represent another vulnerable group. The first MMR dose is not typically administered until age 12-15 months, leaving the youngest children dependent on surrounding vaccination rates [13].

The Financial Toll of Outbreak Response

Each confirmed measles case triggers a resource-intensive public health response: case investigation, contact tracing, quarantine protocols, and often emergency vaccination campaigns. Research from Johns Hopkins School of Public Health analyzing all US measles outbreaks between 2000 and 2025 found that the average cost per case ranged from $9,431 to $243,615, with an overall average of approximately $43,000 [14].

The economics of outbreak response are front-loaded. A single case triggers a fixed investigation cost of approximately $244,480, regardless of whether additional cases follow. Each additional case adds roughly $16,197 in incremental costs [14]. An outbreak of five cases costs an estimated $325,466; an outbreak of 50 cases, approximately $1,054,337 [14]. Cost per contact — the expense of tracking down, notifying, and monitoring each person potentially exposed — ranged from $98 to $910 [14].

Extrapolating from these figures, the current outbreak's financial burden is substantial. With more than 4,000 total cases across 2025-2026, direct public health response costs alone have plausibly exceeded $100 million, though no official consolidated estimate has been published. If the outbreak reaches the scale where sustained endemic transmission is confirmed, costs would escalate further as surveillance and response efforts become permanent rather than episodic.

Why Elimination Is Unraveling

The United States achieved measles elimination in 2000, defined by the Pan American Health Organization (PAHO) as the interruption of endemic virus transmission for 12 or more consecutive months in the presence of adequate surveillance [15]. Maintaining that status required sustained high vaccination rates and rapid containment of imported cases. Several factors have eroded both.

Expanding non-medical exemptions. Since 2000, multiple states have broadened or loosened non-medical exemptions to school vaccination requirements. Philosophical and religious exemptions have allowed clusters of unvaccinated children to accumulate in specific communities, creating the conditions for outbreaks once the virus is introduced [4].

Vaccine hesitancy amplified by social media. The discredited 1998 Lancet study linking MMR to autism — retracted in 2010, with its author Andrew Wakefield stripped of his medical license — continues to circulate online [16]. Social media platforms have amplified vaccine-skeptical content, and public confidence in vaccines has declined. An Annenberg Public Policy Center survey found that perceptions of MMR vaccine safety dropped as measles cases rose in 2025 [16].

Pandemic disruptions. COVID-19 lockdowns between 2020 and 2022 interrupted routine childhood immunization schedules worldwide. In the US, kindergarten MMR coverage dropped from 95.2% in 2019-2020 to 93.9% in 2020-2021 and has not recovered [4].

Public health infrastructure cuts. The termination of $11.4 billion in federal health grants in March 2025 reduced state and local capacity for vaccination outreach and disease surveillance [11]. Additionally, leadership instability at the CDC — which has lacked a Senate-confirmed director for much of the outbreak period — has drawn criticism from public health officials who argue it has hampered coordination [17].

Mixed messaging from federal officials. Public health observers have noted that statements from HHS leadership, including Secretary Robert F. Kennedy Jr., have at times sent conflicting signals about the urgency of vaccination during the outbreak [17]. Kennedy has a long history of questioning vaccine safety, and his appointment to lead HHS was controversial among public health professionals.

The relative contribution of each factor is debated. A February 2026 analysis in News Medical argued that the outbreaks "expose policy failures, not just vaccine hesitancy," pointing to systemic underfunding and exemption expansion as structural causes that precede and amplify the effects of individual hesitancy [18].

The Vaccine Safety Question

Parents who decline MMR vaccination cite a range of concerns. The scientific literature has addressed the most prominent ones.

Autism. The hypothesized link between MMR and autism has been studied more extensively than perhaps any other vaccine safety question. Multiple large-scale studies — including a 2019 Danish cohort study of more than 650,000 children — have found no association [16]. The original 1998 claim was based on fraudulent data and has been retracted. The scientific consensus on this question is unambiguous.

Vaccine schedule timing. Some parents express concern about administering multiple vaccines simultaneously or prefer a delayed schedule. The CDC's recommended schedule has been evaluated through the Vaccine Safety Datalink and other surveillance systems. A study published in Vaccine found that serious outcomes after MMR vaccination occurred at a rate of 6 per 100,000 doses or less for each outcome assessed [19]. Common non-serious side effects — injection site soreness, short-term fever, mild rash — occurred at rates of 3.4 to 263 per 100,000 doses [19]. No peer-reviewed evidence supports the claim that the current schedule is less safe than alternative spacing.

Ingredients and adjuvants. Questions about vaccine ingredients, including preservatives and adjuvants (substances added to enhance immune response), have been examined in multiple systematic reviews. The MMR vaccine does not contain thimerosal, the mercury-based preservative that was a focus of earlier concerns and was removed from most childhood vaccines by 2001 as a precautionary measure [16].

Areas of ongoing research include optimizing vaccine schedules for specific populations, such as infants under 12 months in outbreak settings, and monitoring adverse events in immunocompromised individuals who may inadvertently receive live vaccines [19]. These are questions about clinical optimization, not about whether the MMR vaccine is safe and effective — a point on which the evidence is consistent across decades of research.

International Comparisons

The US is not alone in facing measles resurgence, but its trajectory stands out among peer nations.

The United Kingdom saw measles cases jump from 2 confirmed cases in 2021 to 2,911 in 2024 [10]. Canada's coverage dropped to approximately 82% and the country lost its measles elimination status in 2025 after endemic transmission persisted for more than 12 months [6]. The European region as a whole reported 127,350 cases in 2024 [10].

Several countries have adopted policy mechanisms that the US lacks at the federal level. Australia's "No Jab, No Pay" policy withholds certain family tax benefits and childcare subsidies for parents who do not vaccinate their children, and has been credited with increasing coverage [10]. Germany implemented mandatory measles vaccination for school and daycare enrollment in 2020 [10]. Italy enacted similar requirements following outbreaks in 2017.

In the US, vaccination requirements are set at the state level, and the breadth of allowable exemptions varies widely. Mississippi and West Virginia, which until recently permitted only medical exemptions, have historically maintained among the highest vaccination rates in the country [4]. States with broader philosophical or religious exemptions tend to have lower coverage and more frequent outbreaks.

Elimination Status: What's at Stake

In November 2025, PAHO declared that the Region of the Americas had lost its verification as free from endemic measles transmission — the first time any WHO region has lost a measles elimination designation [6]. The determination was driven primarily by Canada, where a single virus lineage circulated for more than 12 months. The US was designated as maintaining elimination "with major concerns" [15].

PAHO initially scheduled a review of the US status for April 2026 but postponed it to November 2026 [15]. The CDC is conducting genetic sequencing of virus samples from current outbreaks to determine whether they represent a single continuous transmission chain — which would indicate endemic circulation — or separate importation events [15].

The formal criteria are specific: a country loses elimination status if a single measles virus genotype circulates continuously for 12 or more months [15]. If the US loses this designation, the consequences extend beyond symbolism.

Loss of elimination status would mean measles is once again considered permanently circulating in the US rather than limited to imported cases and their immediate contacts. Public health departments would need to maintain ongoing surveillance and response capacity indefinitely rather than deploying it episodically. School and daycare closures during transmission peaks would become more frequent. The reputational impact could affect international health cooperation — the Americas was the first WHO region to achieve measles elimination, and losing it would signal a reversal of one of the most significant public health achievements of the past half-century.

There are also practical implications for healthcare systems. Endemic measles would increase hospitalizations, particularly among young children and immunocompromised patients. Approximately one in four measles patients requires hospitalization, and complications include pneumonia, encephalitis (brain swelling), and, in rare cases, death [7].

What Happens Next

The November 2026 PAHO review will be the most consequential assessment of US measles control in decades. Between now and then, the trajectory of the outbreak — and the vaccination coverage data from the upcoming school year — will determine whether the US can demonstrate that it has interrupted endemic transmission.

The Maryland case, traced to international travel rather than domestic transmission, illustrates both the ongoing importation risk and the importance of community-level vaccination coverage. Maryland's 96.4% statewide coverage provides substantial protection, but Kent County's 88% rate shows how local gaps can create vulnerability even in otherwise well-vaccinated states [9].

With 33 jurisdictions reporting cases in 2026, the outbreak's geographic breadth is already wider than 2019's. Whether it ultimately leads to the loss of elimination status depends on molecular evidence — specifically, whether CDC genetic analysis finds a single lineage circulating continuously — and on whether state and local health departments can contain transmission chains before they reach the 12-month threshold.

The tools to stop measles are well-established and unchanged: two doses of MMR vaccine provide 97% protection against the disease [7]. The question is whether the political, institutional, and social conditions exist to deploy them at the coverage levels required.